Revolution Medicines, Inc.
RVMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $543 | $696 | $161 | $108 |
| Short-Term Investments | $1,746 | $1,157 | $484 | $469 |
| Receivables | $0 | $1 | $5 | $6 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $38 | $25 | $11 | $7 |
| Total Curr. Assets | $2,328 | $1,879 | $660 | $590 |
| Property Plant & Equip (Net) | $142 | $100 | $74 | $71 |
| Goodwill | $15 | $15 | $15 | $15 |
| Intangibles | $57 | $58 | $59 | $60 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $18 | $10 | $5 | $2 |
| Total NC Assets | $231 | $182 | $152 | $148 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,558 | $2,062 | $812 | $738 |
| Liabilities | – | – | – | – |
| Payables | $54 | $62 | $21 | $14 |
| Short-Term Debt | $13 | $7 | $7 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $4 | $12 |
| Other Curr. Liab. | $97 | $75 | $29 | $28 |
| Total Curr. Liab. | $164 | $144 | $62 | $60 |
| LT Debt | $123 | $81 | $57 | $60 |
| Deferred Rev, NC | $0 | $0 | $0 | $7 |
| Deferred Tax Liab, NC | $2 | $3 | $7 | $7 |
| Other NC Liab. | $4 | $8 | $0 | $1 |
| Total NC Liab. | $129 | $92 | $65 | $75 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $136 | $88 | $64 | $67 |
| Total Liabilities | $293 | $236 | $127 | $135 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,738 | -$1,138 | -$701 | -$453 |
| AOCI | $1 | $1 | -$2 | -$0 |
| Other Equity | $4,002 | $2,963 | $1,388 | $1,056 |
| Total Equity | $2,265 | $1,826 | $685 | $603 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,558 | $2,062 | $812 | $738 |
| Net Debt | -$407 | -$608 | -$97 | -$42 |